Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNONW) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to $8250.0.

  • Tenon Medical's Shares Outstanding (Diluted Average) rose 84070.7% to $8250.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8250.0, marking a year-over-year increase of 84070.7%. This contributed to the annual value of $1214.0 for FY2024, which is 43480.18% up from last year.
  • Latest data reveals that Tenon Medical reported Shares Outstanding (Diluted Average) of $8250.0 as of Q3 2025, which was up 84070.7% from $7591.0 recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's Shares Outstanding (Diluted Average) registered a high of $8422.0 during Q2 2022, and its lowest value of $227.0 during Q4 2023.
  • For the 5-year period, Tenon Medical's Shares Outstanding (Diluted Average) averaged around $2183.2, with its median value being $954.5 (2021).
  • As far as peak fluctuations go, Tenon Medical's Shares Outstanding (Diluted Average) plummeted by 8450.49% in 2023, and later skyrocketed by 151855.01% in 2025.
  • Tenon Medical's Shares Outstanding (Diluted Average) (Quarter) stood at $903.0 in 2021, then fell by 11.3% to $801.0 in 2022, then crashed by 71.66% to $227.0 in 2023, then soared by 434.8% to $1214.0 in 2024, then surged by 579.57% to $8250.0 in 2025.
  • Its last three reported values are $8250.0 in Q3 2025, $7591.0 for Q2 2025, and $3597.0 during Q1 2025.